| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Design Therapeutics, Inc. | Director | Common Stock | 3M | $12.8M | $4.25 | Aug 9, 2024 | By Logos Global Master Fund LP |
| Design Therapeutics, Inc. | Director | Common Stock | 1.22M | $5.17M | $4.25 | Aug 9, 2024 | By Logos Opportunities Fund II, L.P. |
| Design Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $4.25 | Aug 9, 2024 | By Logos SPV I LP |
| Design Therapeutics, Inc. | Director | Stock Option (right to buy) | 19K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | Aug 9, 2024 | 1 | -$3.46M | 4 | Aug 12, 2024 | Director |
| DSGN | Design Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| DSGN | Design Therapeutics, Inc. | Aug 28, 2023 | 2 | $5.37M | 4 | Aug 30, 2023 | Director |
| DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| DSGN | Design Therapeutics, Inc. | Mar 21, 2022 | 1 | $475K | 4 | Mar 22, 2022 | Director |
| DSGN | Design Therapeutics, Inc. | Aug 31, 2021 | 1 | $618K | 4 | Sep 2, 2021 | Director |
| DSGN | Design Therapeutics, Inc. | Mar 30, 2021 | 3 | $14M | 4/A | Sep 6, 2023 | Director |